AVY
54
-14
FOX
39
2
IR
69
-2
NUE
50
3
EXPE
74
2
PEP
50
-4
SRE
54
-5
BLK
69
2
FTI
69
-7
CTAS
56
-5
TAP
51
-2
KLAC
56
-3
MMC
60
-2
V
64
-4
STI
3
-9
EBAY
50
-3
AAL
47
-3
AVB
65
-2
NSC
62
2
MSI
69
-3
AVY
54
-14
FOX
39
2
IR
69
-2
NUE
50
3
EXPE
74
2
PEP
50
-4
SRE
54
-5
BLK
69
2
FTI
69
-7
CTAS
56
-5
TAP
51
-2
KLAC
56
-3
MMC
60
-2
V
64
-4
STI
3
-9
EBAY
50
-3
AAL
47
-3
AVB
65
-2
NSC
62
2
MSI
69
-3
Financhill
Back

Novo Nordisk AS 10K Form

Sell
43

NVO
Novo Nordisk AS

Last Price:
134.90
Seasonality Move:
4.32%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NVO News And Ratings

See the #1 stock for the next 7 days that we like better than NVO

NVO Financial Statistics

Sales & Book Value

Annual Sales: $33.72B
Cash Flow: $5.37B
Price / Cash Flow: 62.17
Annual Sales: $3.63
Price / Book: 36.39

Profitability

EPS (TTM): 2.91420
Net Income (TTM): $13.05B
Gross Margin: $28.53B
Return on Equity: 89.79%
Return on Assets: 28.81%

Novo Nordisk AS Earnings Forecast

Key Novo Nordisk AS Financial Ratios

  • The Gross Profit Margin over the past 40 years for NVO is 84.60%.
  • The Selling, General & Administrative Expenses for NVO have been equal to 26.52% of Gross Profit Margin.
  • The Research & Development expenses have been 13.97% of Revenue.
  • The Interest Expense is 0.65% of Operating Income.
  • The Net Earning history of NVO is 36.03% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 35 years.

Novo Nordisk AS Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: NVO
CUSIP: 670100
Website: novonordisk.com

Debt

Debt-to-Equity Ratio: 0.51
Current Ratio: 0.94
Quick Ratio: 0.74

Price-to-Earnings

Trailing P/E Ratio: 48.85
Forward P/E Ratio: 30.76

NVO Technical Analysis vs Fundamental Analysis

Sell
43
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy or a Sell?

  • Novo Nordisk AS stock is rated a Sell
    The current Novo Nordisk AS [NVO] share price is $132.06. The Score for NVO is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.